RAD51 and cancer: Studies have shown that miR-506 specifically targets the 3'-UTR of RAD51, thereby suppressing RAD51 gene expression, impairing the DNA damage response pathway, and enhancing chemosensitivity both in vitro and in vivo, ultimately reducing cancer cell growth (111, 166, 167).